2 Beaten-Down Stocks That Could Be About to Rally

Group 1: Investment Opportunities - Investing in beaten-down stocks with promising outlooks can yield above-average market returns over the long run [1] - Novo Nordisk and Regeneron Pharmaceuticals are highlighted as potential investment opportunities due to their promising prospects [2] Group 2: Novo Nordisk - Novo Nordisk has several catalysts that could improve its stock performance, including late-stage studies nearing regulatory submissions, particularly the CagriSema medicine, which is projected to generate $15.2 billion in annual sales by 2030 [4][5] - The potential launch of an oral semaglutide formulation for weight management could enhance Novo Nordisk's competitive position against Eli Lilly, as it is expected to be cheaper and increase access for cash-paying customers [6] - Recent label expansions for existing products are anticipated to positively impact Novo Nordisk's financial results, and its revenue and earnings growth remain stronger than most peers, making it an attractive investment opportunity at current valuations [7][8] Group 3: Regeneron Pharmaceuticals - Regeneron is effectively managing biosimilar competition while introducing new products to mitigate threats [9]